These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36870882)
1. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia. Thayabaran D; Tsui APT; Ebmeier S; Cegla J; David A; Jones B J Clin Lipidol; 2023; 17(2):244-254. PubMed ID: 36870882 [TBL] [Abstract][Full Text] [Related]
2. Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic? Chan DC; Pang J; Hooper AJ; Bell DA; Burnett JR; Watts GF Clin Chem; 2019 Oct; 65(10):1258-1266. PubMed ID: 31307996 [TBL] [Abstract][Full Text] [Related]
3. Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemia. Tromp TR; Ibrahim S; Nurmohamed NS; Peter J; Zuurbier L; Defesche JC; Reeskamp LF; Hovingh GK; Stroes ESG Atherosclerosis; 2023 Jan; 365():27-33. PubMed ID: 36473758 [TBL] [Abstract][Full Text] [Related]
4. Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation. Fatica EM; Meeusen JW; Vasile VC; Jaffe AS; Donato LJ Clin Biochem; 2020 Dec; 86():45-51. PubMed ID: 32997972 [TBL] [Abstract][Full Text] [Related]
5. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels. Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647 [TBL] [Abstract][Full Text] [Related]
8. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study. Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354 [TBL] [Abstract][Full Text] [Related]
10. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia. Chan DC; Pang J; Hooper AJ; Bell DA; Bates TR; Burnett JR; Watts GF J Clin Endocrinol Metab; 2018 Apr; 103(4):1704-1714. PubMed ID: 29408959 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population. Abdul-Razak S; Rahmat R; Mohd Kasim A; Rahman TA; Muid S; Nasir NM; Ibrahim Z; Kasim S; Ismail Z; Abdul Ghani R; Sanusi AR; Rosman A; Nawawi H BMC Cardiovasc Disord; 2017 Oct; 17(1):264. PubMed ID: 29037163 [TBL] [Abstract][Full Text] [Related]
12. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care. Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577 [TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales. Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study. de Boer LM; Hutten BA; Zwinderman AH; Wiegman A Eur Heart J; 2023 Apr; 44(16):1421-1428. PubMed ID: 36382390 [TBL] [Abstract][Full Text] [Related]
15. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease. Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649 [TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505 [TBL] [Abstract][Full Text] [Related]
17. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). Miller PE; Martin SS; Toth PP; Santos RD; Blaha MJ; Nasir K; Virani SS; Post WS; Blumenthal RS; Jones SR J Clin Lipidol; 2015; 9(5):676-83. PubMed ID: 26350814 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil. Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098 [TBL] [Abstract][Full Text] [Related]
19. A service evaluation: impact of nurse-led regional familial hypercholesterolaemia service on a hospital adult lipid clinic. Wilkinson B; George E; Horton S; Bellaby J; Min SS; Gama R Br J Nurs; 2020 Nov; 29(20):1206-1208. PubMed ID: 33180610 [TBL] [Abstract][Full Text] [Related]